|
|
||||||||
Nuclear Cardiology Laboratory, Division of Cardiology, Memorial Hospital of Rhode Island, Pawtucket
Brown University School of Medicine, Providence, Rhode Island
Correspondence: For correspondence or reprints contact: Gary V. Heller, MD, PhD, Director, Nuclear Cardiology, Division of Cardiology, Memorial Hospital of Rhode Island, 111 Brewster St., Pawtucket, RI 02860
ABSTRACT
We report on an 80-yr-old patient with a history of inferior myocardial infarction. The patient was injected with 15 mCi of 99mTc-sestamibi when an electrocardiogram revealed new asymptomatic inferolateral ST-segment depressions. A second 99mTc study was performed 72 hr after the initial injection and after ST-segment changes had resolved. Scintigraphic acquisitions using SPECT revealed a large reduction in photon activity in the inferolateral and inferoposterior walls with 70%80% normalization. Therefore, 99mTc-sestamibi imaging is useful in assessing asymptomatic silent myocardial ischemia.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |